Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
galectin therapeutics和其他2只股票低於$5，內部人員正在購買
The Dow Jones index closed lower by over 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週二收跌50多點。內部人士購買或出售股票時，表明他們對公司前景的信心或關注。有興趣購買便士股票的投資者和交易員可以考慮這一因素，作爲他們整體投資或交易決策的因素之一。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。
Bespoke Extracts
Bespoke Extracts
- The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod bought a total of 3,000 shares at an average price of $0.07. To acquire these shares, it cost around $210.
- What's Happening: The company's stock jumped around 51% over the past six months.
- What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.
- 交易：Bespoke Extracts公司（OTC：BSPK）的CEO Michael Feinsod以平均價格0.07美元購買了總計3,000股股票。購買這些股票需要花費約210美元。
- 近六個月以來，該公司的股票上漲了大約51％。
- Bespoke Extracts Inc專注於銷售其專有系列的特製、優質、大麻衍生的CBD產品。
Galectin Therapeutics
Galectin Therapeutics
- The Trade: Galectin Therapeutics Inc. (NASDAQ:GALT) Director Kary Eldred acquired a total of 400 shares at an average price of $2.39. To acquire these shares, it cost around $956.00.
- What's Happening: On May 15, Galectin Therapeutics posted a wider-than-expected quarterly loss.
- What Galectin Therapeutics Does: Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company.
- 交易：Galectin Therapeutics公司（NASDAQ：GALT）的董事Kary Eldred以平均價格2.39美元購買了總計400股股票。購買這些股票需要花費約956.00美元。
- 5月15日，Galectin Therapeutics發佈了超出預期的季度虧損。
- Galectin Therapeutics Inc是一家臨床階段生物製藥公司。
RENN Fund
renn fund
- The Trade: RENN Fund, Inc. (NYSE:RCG) President and CEO Murray Stahl acquired a total of 1,499 shares at an average price of $1.81. The insider spent around $2,713 to buy those shares.
- What's Happening: RENN Fund shares rose around 7% over the past month.
- What RENN Fund Does: RENN Fund Inc is active in the financial services domain.
- 交易：RENN基金公司（NYSE：RCG）的總裁兼首席執行官Murray Stahl以平均價格1.81美元購買了總共1,499股股票。這位內部人士花費約2,713美元購買了這些股票。
- 近一個月來，RENN Fund股票上漲了約7％。
- RENN Fund Inc在金融服務領域活躍。
- Best Buy, Kroger And 2 Other Stocks Insiders Are Selling
- 百思買、Kroger和其他2只股票的內部人士正在出售